These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Management of thrombosis in the cancer patient. Andrea N; Ansell J J Support Oncol; 2003; 1(4):235-8, 240-2; discussion 239-40, 243-5. PubMed ID: 15334865 [TBL] [Abstract][Full Text] [Related]
25. Deep vein thrombosis and anticoagulant therapy. Sullano MA; Ortiz EJ Nurs Clin North Am; 2001 Dec; 36(4):645-63, v. PubMed ID: 11726345 [TBL] [Abstract][Full Text] [Related]
26. Management of deep vein thrombosis. Chong BH Aust Fam Physician; 2001 Mar; 30(3):235-40. PubMed ID: 11301761 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty. Enoxaparin Clinical Trial Group. Colwell CW; Spiro TE; Trowbridge AA; Stephens JW; Gardiner GA; Ritter MA Clin Orthop Relat Res; 1995 Dec; (321):19-27. PubMed ID: 7497668 [TBL] [Abstract][Full Text] [Related]
28. Comparison of two warfarin regimens in the prevention of venous thrombosis following total knee replacement. Francis CW; Pellegrini VD; Leibert KM; Totterman S; Azodo MV; Harris CM; Cox C; Marder VJ Thromb Haemost; 1996 May; 75(5):706-11. PubMed ID: 8725709 [TBL] [Abstract][Full Text] [Related]
29. [Hemodilution: importance and validity in the prevention of deep venous thrombosis]. d'Alessandro A; Impagliatelli M Minerva Cardioangiol; 1987 May; 35(5):287-9. PubMed ID: 3627481 [No Abstract] [Full Text] [Related]
30. Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement. O'Brien BJ; Anderson DR; Goeree R CMAJ; 1994 Apr; 150(7):1083-90. PubMed ID: 8137188 [TBL] [Abstract][Full Text] [Related]
33. Exploring the role of low-molecular-weight heparins in pregnancy. Greer IA Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():25-31. PubMed ID: 12232820 [TBL] [Abstract][Full Text] [Related]
34. Preventing DVT following total knee replacement: a review of recent clinical trials. Fitzgerald RH Orthopedics; 1995 Jul; 18 Suppl():10-1. PubMed ID: 7479418 [TBL] [Abstract][Full Text] [Related]
35. Prevention of deep venous thrombosis by a new low molecular weight heparin (Fluxum) in cardiac surgery. Beghi C; Fragnito C; Antonelli A; Reverberi C; Ferrari P; Saccani S; Fesani F Int Angiol; 1993 Dec; 12(4):383-6. PubMed ID: 8207317 [TBL] [Abstract][Full Text] [Related]
36. DVT and pulmonary embolism: Part II. Treatment and prevention. Ramzi DW; Leeper KV Am Fam Physician; 2004 Jun; 69(12):2841-8. PubMed ID: 15222649 [TBL] [Abstract][Full Text] [Related]
38. [Ineffectiveness of preventive low-dose heparin administration in pacemaker implantation]. Münch U; Mombelli G Schweiz Med Wochenschr; 1980 Jul; 110(30):1125-8. PubMed ID: 7423159 [TBL] [Abstract][Full Text] [Related]
39. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group. Bergmann JF; Neuhart E Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991 [TBL] [Abstract][Full Text] [Related]
40. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]